Clinical Trial 55269

Berlin, NJ 08009


Summary:

A 6-Month Phase 3, Multicenter, Prospective, Randomized, Double-Blind, Vehicle-Controlled Study, to Evaluate the Efficacy and Safety of Topically Applied Clascoterone (Cortexolone 17?-Propionate) Solution for the Treatment of Androgenetic Alopecia in Males, Followed by a 6-Month Single-Blind Treatment with Clascoterone or Vehicle BID Solution



Criteria:
  • Male
  • At least 18 years old
  • Have mild to moderate androgenetic alopecia (male pattern baldness)
    • Must be rating 3 vertex to 5
  • History of ongoing hair loss
  • Additional criteria apply


Qualified Participants May Receive:

Compensation up to $925–$1,175 for time and travel-related expenses


Available At:

CenExel HRI
175 Berlin-Cross Keys Rd. Suite 109
Berlin, NJ 08009
View Clinic Location

 


If you or someone you care for is interested in participating and lives within 50 miles of the location shown, please complete the form below and click 'Submit'

Clinical trials are medical research studies designed to test the safety and/or effectiveness of new investigational drugs, devices, or treatments in humans. These studies are conducted worldwide for a range of conditions and illnesses. Learn more about clinical research and participating in a study at About Clinical Trials.